A Case of Autosomal Dominant Osteopetrosis Type 2 with a CLCN7 Gene Mutation
- PMID: 30759959
- PMCID: PMC6878338
- DOI: 10.4274/jcrpe.galenos.2019.2018.0229
A Case of Autosomal Dominant Osteopetrosis Type 2 with a CLCN7 Gene Mutation
Abstract
Osteopetrosis is a rare genetic disease characterized by increased bone density and bone fractures due to defective osteoclast function. Autosomal dominant osteopetrosis type 2 (ADO-2), Albers-Schonberg disease, is characterized by the sclerosis of bones, predominantly involving the spine, pelvis and the base of the skull. Here, we report a typical case of osteopetrosis in a 17.7-year-old male who carries a heterozygous c.746C>T mutation in exon 9 in the chloride voltage-gated channel 7 (CLCN7) gene. The patient’s spine showed multiple sclerotic changes including sandwich vertebra. His father had the same mutation but his skeletal radiographs were normal. This is the first reported case of ADO-2, confirmed by genetic testing in a Korean patient.
Keywords: Osteopetrosis; bone density; osteoclast; sclerosis; mutation.
Figures


Similar articles
-
Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients.Osteoporos Int. 2016 Mar;27(3):1047-1055. doi: 10.1007/s00198-015-3320-x. Epub 2015 Sep 22. Osteoporos Int. 2016. PMID: 26395888
-
Type II benign osteopetrosis (Albers-Schönberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations.Calcif Tissue Int. 2004 Jan;74(1):42-6. doi: 10.1007/s00223-002-1087-5. Epub 2003 Nov 26. Calcif Tissue Int. 2004. PMID: 14564431
-
Two novel mutations of CLCN7 gene in Chinese families with autosomal dominant osteopetrosis (type II).J Bone Miner Metab. 2016 Jul;34(4):440-6. doi: 10.1007/s00774-015-0682-2. Epub 2015 Jun 9. J Bone Miner Metab. 2016. PMID: 26056022
-
Autosomal dominant osteopetrosis.Bone. 2023 May;170:116723. doi: 10.1016/j.bone.2023.116723. Epub 2023 Feb 28. Bone. 2023. PMID: 36863500 Free PMC article. Review.
-
Autosomal dominant osteopetrosis revisited: lessons from recent studies.Eur J Endocrinol. 2013 Jul 13;169(2):R39-57. doi: 10.1530/EJE-13-0136. Print 2013 Aug. Eur J Endocrinol. 2013. PMID: 23744590 Review.
Cited by
-
Evaluating the Anti-Osteoporotic Potential of Mediterranean Medicinal Plants: A Review of Current Evidence.Pharmaceuticals (Basel). 2024 Oct 8;17(10):1341. doi: 10.3390/ph17101341. Pharmaceuticals (Basel). 2024. PMID: 39458982 Free PMC article. Review.
-
Autosomal dominant osteopetrosis type II resulting from a de novo mutation in the CLCN7 gene: A case report.World J Clin Cases. 2022 Jul 16;10(20):6936-6943. doi: 10.12998/wjcc.v10.i20.6936. World J Clin Cases. 2022. PMID: 36051116 Free PMC article.
-
Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases.Int J Mol Sci. 2022 Jan 28;23(3):1500. doi: 10.3390/ijms23031500. Int J Mol Sci. 2022. PMID: 35163424 Free PMC article. Review.
References
-
- Superti-Furga A, Unger S. Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet A. 2007;143:1–18. - PubMed
-
- Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med. 2004;351:2839–2849. - PubMed
-
- Bénichou OD, Laredo JD, de Vernejoul MC. Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. Bone. 2000;26:87–93. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources